Introduction
Spnib 50mg tablet:

Spnib 50mg tablet consists of the active ingredient Dasatinib. It is
prescribed for adults and children above one year of age with Chronic Myeloid
Leukemia. This medicine is used to treat newly diagnosed Philadelphia
chromosome-positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase
and Ph+ acute lymphoblastic leukemia in patients resistant to other therapies.
Chronic Myeloid Leukemia refers to a type of blood cancer that makes the body
produce too many white blood cells that happen due to alteration in the
Philadelphia chromosome. Acute Lymphoblastic Leukemia is the most common form
of blood cancer that affects children. In this case, the lymphocytes of white
blood cells multiply too quickly and live too long.

The common side effects that are likely to associate with Spnib 50mg
tablet are diarrhea, headache, cough, rash, nausea, tiredness, vomiting, muscle
pain, weakness, low appetite, and high or low blood pressure. Inform your
doctor if these side effects disturb or persist you.

Inform your doctor if you are allergic to Dasatinib and its ingredients.
Before starting treatment with this medication, you should let your physician
know if you have liver or heart problems, breathing difficulties, chest pain,
cough, hepatitis B infection, or bleeding problems. This medicine could cause a
severe reduction in the number of platelets, WBC, or RBC in the blood. Ensure
that your physician monitors your blood levels at regular intervals. Tell your
healthcare professional about all the medicines you take, including
prescription and over-the-counter medicines, vitamins, antacids, and herbal
supplements. It is not recommended for children below one year of age.

Uses of Spnib 50mg tablet:

·
Children and adults with chronic myeloid leukemia.

·
Adults with Philadelphia chromosome-positive acute
lymphoblastic leukemia (Ph+ ALL) with resistance to prior therapy.

How
to consume Spnib 50mg tablet:

Take the tablet with or without food at the same time each day. Do not
break, crush or chew the tablet. Your doctor will decide the dose and frequency
of Spnib 50mg tablet administration based on your disease severity and other
factors. Do not stop taking the tablet without consulting your healthcare
professional.